Abstract:Background It is thought that Rheumatoid arthritis (RA) arises from a breakdown in immunological self-tolerance. We have givena direct evidence for this conceptionthat absolute number of peripheral CD4+Regulatory T-cells (Tregs) decreased inRA patients[1]. Furthermore, rapamycin can significantly induce immune tolerance through up-regulate Tregs and down-regulate Th17 cells[2]. Objectives To investigate the effect of rapamycin on the absolute numbers of Th17 and Treg cells and on maintenance of disease remission in RA patients instead of DMARDs. Methods Thirty-two patients, who achieved remission(DAS28 ≤2.6) by the treatment with two kinds of DMARDs for more than half a year, received rapamycin at a dose of 0.5 mg every other dayfor 12 weeks. Before and after treatment with rapamycin, thediseaseactivity and immunological assessments of them were performed. In this study, BD Trucount tubes with the lyophilized pellet of a known number of internal counting beads were used for determining absolute counts of total CD4+ T cells in peripheral blood and then calculating the absolute number of Th17 cells and CD4+Tregs. Results At week 12, 65.6% of the patients maintained remission (DAS28 ≤2.6). TheDAS28 was increased from a median of 2.03(at week 0) to 2.15(at week 12) (p>0.05). The absolute numberof Treg cells was increased significantly from a median of 22.16(at week 0) to 32.19(at week 12) (P=0.039). The absolute number of Th17 cells was decreased from a median of5.98(at week 0) to 5.56(at week 12) (p>0.05). The ratio of Th17/Treg cells was also decreased from a median of 0.245(at week 0) to 0.19(at week 12) (p>0.05). At the same time, the mean dosage of prednisone decreased from 6.29 mg/d to 5.35 mg/d and thatof DMARDs were also reduced from93.75% to 56.25%. Conclusions Rapamycin was effective in the maintenance of remission(DAS28 ≤2.6)by increase of Treg cells and correcting the imbalance of Th17/Treg cells. Meantime, the mean dosage of conventional drugs such as glucocorticoid and DMARDs gradually decreased. In the future, rapamycin may replace current immunosuppressant for treatment of RA. References [1] Niu H, Li Z, He J, et al. Rapamycin selectively increases circulating Treg cells and modulates the imbalance of Th17/Treg cells in patients with low active rheumatoid arthritis. [2] Yang X, Yao Q, Hu X, et al. Rapamycin-conditioned dendritic cells induced immune tolerance through the regulation of Treg/Th17 cells in mice. Zhonghua Yi Xue Za Zhi2015Aug 11;95(30):2469–73. Disclosure of Interest None declared

RANTES Produced by Actiated Lymphocytes Costimulated by Anti-CD3 Mab and Anti-CD28 Mab

Effect of CsA on T Cell Activation CD28 Pathway

[Epigallocatechin Gallate Attenuates the Expression of Regulated Upon Activation Normal T Cell Expressed and Secreted Induced by Lipopolysaccharide in Human Retinal Endothelial Cells].

Immune activation gene mRNA expression in CD28 pathway activated lymphocyte and the suppressive effect of cyclosporin A

The Serum Levels and Roles of Regulated Upon Activation Normal T Cell Expressed and Secreted and Monocyte Chemoattractant Protein-1 in Human Immunodeficiency Virus-1 Infected Patients

Effects of Cyclosporin A on CD28/CTLA4 and CD40/CD40L Co-Stimulated Lymphocyte Proliferation

CD28 confers CD4+ T cells with resistance to cyclosporin A and tacrolimus but to different degrees

RANTES Deficiency Attenuates Autoantibody-Induced Glomerulonephritis

Effects of immunosuppressants on co-stimulated lymphocyte's Th1/Th2 cytokine production

AB0382 Rapamycin Selectively Increases Circulating Tregcellsand Maintain Remission of Patients with Rheumatoid Arthritis

Stephanthraniline A And Cyclosporine A Synergize To Inhibit T-Cell Response In Vitro And In Vivo

Effects of CD28 Superagonist Antibody on Immune Inflammatory Reaction Early after Orthotopic Tracheal Transplantation in Rats

The Expression of the Costimulatory Molecule CD28 and Its Clinical Significance in Patients with Primary Nephrotic Syndrome

Strong CD28 Costimulation Suppresses Induction of Regulatory T Cells from Naïve Precursors Through Lck Signaling.

[Regulatory Function of Tacrolimus and CsA on CD4/CD8 T Lymphocyte Subgroups and Costimulators on Them in Allo-Liver Recipients].

CD3/CD28 Costimu Lation-Induced Resistance to HIV-1 Infection and Cell Subsets Analysis

CD28 costimulation is essential for human T regulatory expansion and function

The Changes of Serum RANTES and MCP-1 Following Cardiac Transplantation in Rats and Implication

A Potential Side Effect of Cyclosporin A: Inhibition of CD4+CD25+ Regulatory T Cells in Mice

The Influence of Cyclosporin A on Lymphocyte Attenuator Expression

Anti-CD3antibody-induced Expression Ofbothp55andp75chains Ofthehighaffinity Interleukin-2 Receptor on Humant Lymphocytes Isinhibited Bycyclosporin A